NASDAQ:BABYNatus Medical Stock Price, Forecast & News Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Natus Medical Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $20.90 -1.07 (-4.87 %) (As of 04/5/2020 04:00 PM ET) Add Compare Share Today's Range$20.63Now: $20.90▼$22.4550-Day Range$26.75MA: $29.96▼$31.9252-Week Range$23.53Now: $20.90▼$37.90Volume273,956 shsAverage Volume165,325 shsMarket Capitalization$710.81 millionP/E Ratio14.72Dividend YieldN/ABeta0.57 ProfileAnalyst RatingsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Natus Medical Incorporated provides neurology, newborn care, and hearing and balance assessment healthcare products and services worldwide. It offers products and services used for the screening, diagnosis, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction and neurosurgical treatments, epilepsy, sleep disorders, neuromuscular diseases, and balance and mobility disorders. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. In addition, it offers electroencephalography, long term monitoring, intensive care unit monitoring, electromyography, sleep analysis or polysomnography, and intra-operative monitoring solutions. Further, the company provides hearing screening products; diagnostic hearing assessment products to screen for/or diagnose hearing loss, or to identify abnormalities affecting the peripheral and central auditory nervous systems; balance and mobility systems to diagnose and assist in treating balance disorders; and thermoregulation products to control the incubators and warmers. Additionally, it offers jaundice management products; brain injury products; NICVIEW, a live streaming video for families with babies in the neonatal intensive care unit (NICU); essential products used in the everyday operation of NICU; and eye imaging systems and products used in the advanced science and practice of neonatal and pediatric retinal imaging. The company also provides computer-based audiological, otoneurologic, and vestibular instrumentation and sound rooms to hearing and balance care professionals. It serves hospitals, clinics, laboratories, physicians, nurses, audiologists, and governmental agencies. Natus Medical Incorporated was incorporated in 1987 and is headquartered in Pleasanton, California.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Natus Medical. Previous Next 2.4 Community Rank Outperform VotesNatus Medical has received 293 “outperform” votes. (Add your “outperform” vote.)Underperform VotesNatus Medical has received 317 “underperform” votes. (Add your “underperform” vote.)Community SentimentNatus Medical has received 51.97% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Natus Medical and other stocks. Vote “Outperform” if you believe BABY will outperform the S&P 500 over the long term. Vote “Underperform” if you believe BABY will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldNatus Medical does not currently pay a dividend.Dividend GrowthNatus Medical does not have a long track record of dividend growth. Previous Next 1.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Natus Medical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.65% of the stock of Natus Medical is held by insiders.Percentage Held by Institutions91.56% of the stock of Natus Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Natus Medical are expected to grow by 24.41% in the coming year, from $1.27 to $1.58 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Natus Medical is 14.72, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 10.93.Price to Earnings Ratio vs. SectorThe P/E ratio of Natus Medical is 14.72, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 17.09.Price to Book Value per Share RatioNatus Medical has a P/B Ratio of 1.77. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.06 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Electromedical equipment Sub-IndustryHealth Care Equipment SectorMedical Current SymbolNASDAQ:BABY Previous Symbol CUSIP63905010 CIK878526 Webhttp://www.natus.com/ Phone925-223-6700Debt Debt-to-Equity Ratio0.18 Current Ratio1.70 Quick Ratio1.18Price-To-Earnings Trailing P/E Ratio14.72 Forward P/E Ratio16.46 P/E GrowthN/A Sales & Book Value Annual Sales$530.89 million Price / Sales1.34 Cash Flow$2.23 per share Price / Cash Flow9.39 Book Value$11.80 per share Price / Book1.77Profitability EPS (Most Recent Fiscal Year)$1.42 Net Income$-22,930,000.00 Net Margins-7.38% Return on Equity10.79% Return on Assets6.57%Miscellaneous Employees1,729 Outstanding Shares34,010,000Market Cap$710.81 million Next Earnings DateN/A OptionableOptionable Receive BABY News and Ratings via Email Sign-up to receive the latest news and ratings for BABY and its competitors with MarketBeat's FREE daily newsletter. Natus Medical (NASDAQ:BABY) Frequently Asked Questions How were Natus Medical's earnings last quarter? Natus Medical Inc (NASDAQ:BABY) released its quarterly earnings results on Wednesday, October, 24th. The medical equipment provider reported $0.40 earnings per share for the quarter, missing analysts' consensus estimates of $0.42 by $0.02. The medical equipment provider had revenue of $130.60 million for the quarter, compared to analyst estimates of $132.92 million. Natus Medical had a positive return on equity of 10.79% and a negative net margin of 7.38%. The company's revenue was up 6.5% compared to the same quarter last year. During the same period last year, the company earned $0.40 EPS. View Natus Medical's earnings history. Has Natus Medical been receiving favorable news coverage? News headlines about BABY stock have been trending very negative on Sunday, InfoTrie reports. The research firm ranks the sentiment of news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Natus Medical earned a media sentiment score of -3.3 on InfoTrie's scale. They also assigned press coverage about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the near term. View the latest news aboutNatus Medical. Who are some of Natus Medical's key competitors? Some companies that are related to Natus Medical include Abbott Laboratories (ABT), Medtronic (MDT), Becton Dickinson and (BDX), Stryker (SYK), Intuitive Surgical (ISRG), Boston Scientific (BSX), Baxter International (BAX), Edwards Lifesciences (EW), DexCom (DXCM), ResMed (RMD), IDEXX Laboratories (IDXX), Teleflex (TFX), Steris (STE), Insulet (PODD) and Masimo (MASI). What other stocks do shareholders of Natus Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Natus Medical investors own include Starbucks (SBUX), Activision Blizzard (ATVI), Gilead Sciences (GILD), Walt Disney (DIS), Intel (INTC), Skyworks Solutions (SWKS), Celgene (CELG), AbbVie (ABBV), Alphabet (GOOG) and NVIDIA (NVDA). Who are Natus Medical's key executives? Natus Medical's management team includes the following people: Mr. Jonathan A. Kennedy CPA, Pres, CEO & Director (Age 48)Mr. Benjamin Drew Davies, Exec. VP & CFO (Age 53)Mr. Austin F. Noll III, Exec. VP & Chief Commercial Officer (Age 52)Mr. Seán Langan, VP Global OperationsMr. Ivan Pandiyan, VP of Global R&D What is Natus Medical's stock symbol? Natus Medical trades on the NASDAQ under the ticker symbol "BABY." What is Natus Medical's stock price today? One share of BABY stock can currently be purchased for approximately $20.90. How big of a company is Natus Medical? Natus Medical has a market capitalization of $710.81 million and generates $530.89 million in revenue each year. The medical equipment provider earns $-22,930,000.00 in net income (profit) each year or $1.42 on an earnings per share basis. Natus Medical employs 1,729 workers across the globe. View additional information about Natus Medical. What is Natus Medical's official website? The official website for Natus Medical is http://www.natus.com/. How can I contact Natus Medical? Natus Medical's mailing address is 6701 KOLL CENTER PARKWAY SUITE 120, PLEASANTON CA, 94566. The medical equipment provider can be reached via phone at 925-223-6700 or via email at [email protected] This page was last updated on 4/5/2020 by MarketBeat.com StaffFeatured Article: When is a capital gain realized?